X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
a-beta (1527) 1527
alzheimer's disease (1508) 1508
index medicus (1256) 1256
alzheimers-disease (1180) 1180
neurosciences (1138) 1138
humans (1057) 1057
animals (898) 898
amyloid beta-peptides - metabolism (631) 631
biochemistry & molecular biology (607) 607
mice (491) 491
alzheimer disease - metabolism (457) 457
brain (441) 441
male (432) 432
protein (401) 401
oxidative stress (355) 355
alzheimer disease - pathology (349) 349
peptide (344) 344
amyloid beta-peptides - chemistry (319) 319
female (316) 316
transgenic mice (313) 313
peptide fragments - metabolism (312) 312
amyloid-beta (307) 307
clinical neurology (303) 303
peptides (297) 297
aggregation (296) 296
mouse model (292) 292
disease models, animal (273) 273
precursor protein (267) 267
oligomers (266) 266
dementia (265) 265
a beta (264) 264
rats (261) 261
amyloid precursor protein (256) 256
in-vitro (256) 256
mice, transgenic (253) 253
neurodegenerative diseases (248) 248
alzheimers disease (247) 247
proteins (246) 246
alzheimer’s disease (243) 243
neurotoxicity (238) 238
in-vivo (231) 231
neurology (227) 227
pharmacology & pharmacy (226) 226
neurodegeneration (225) 225
cell biology (223) 223
aged (216) 216
pathology (213) 213
brain - metabolism (212) 212
peptide fragments - chemistry (212) 212
amyloid (207) 207
amyloid beta-protein (207) 207
alzheimer disease - drug therapy (204) 204
analysis (204) 204
research (200) 200
mild cognitive impairment (196) 196
neurons (194) 194
alzheimer disease - genetics (190) 190
alzheimer disease (184) 184
neurons - metabolism (179) 179
cells, cultured (175) 175
cerebrospinal-fluid (175) 175
beta-amyloid (173) 173
memory (170) 170
multidisciplinary sciences (169) 169
tau (169) 169
β-amyloid (169) 169
biophysics (166) 166
long-term potentiation (165) 165
amyloid beta-peptides - toxicity (158) 158
toxicity (153) 153
disease (150) 150
aged, 80 and over (149) 149
article (148) 148
fibril formation (147) 147
apoptosis (146) 146
amyloid beta (144) 144
brain - pathology (144) 144
geriatrics & gerontology (144) 144
neurons - drug effects (140) 140
research article (140) 140
inflammation (139) 139
biomarkers (135) 135
cerebrospinal fluid (133) 133
middle aged (133) 133
synaptic plasticity (132) 132
chemistry, medicinal (128) 128
medicine (127) 127
mice, inbred c57bl (126) 126
alzheimer disease - physiopathology (121) 121
pathogenesis (121) 121
phosphorylation (121) 121
amyloid beta-protein precursor - metabolism (120) 120
amyloid-beta-peptide (117) 117
expression (117) 117
amyloid beta-protein precursor - genetics (116) 116
physiological aspects (115) 115
amyloid beta-peptides - genetics (114) 114
central-nervous-system (114) 114
apolipoprotein-e (112) 112
hippocampus (112) 112
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF MOLECULAR BIOLOGY, ISSN 0022-2836, 02/2010, Volume 396, Issue 1, pp. 9 - 18
Aggregation of the amyloid-beta (A beta) peptide is considered a central event in the pathogenesis of Alzheimer's disease (AD). In order to bypass... 
OXIDATION | MECHANISM | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCHERICHIA-COLI | OLIGOMERS | A beta 1-42 | amyloid | neurotoxicity | FIBRILS | ETCH VIRUS PROTEASE | protein misfolding | RELEVANCE | PURIFICATION | Alzheimer's disease | EXPRESSION
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2016, Volume 113, Issue 34, pp. E4976 - E4984
Journal Article
Life Sciences, ISSN 0024-3205, 11/2018, Volume 213, pp. 74 - 81
Increasing evidence displays that deposition of aggregated β-amyloid (Aβ) leads to neuronal cell apoptosis, thus aggravates the pathological progression of... 
ERK1/2 | D3T | PC12 cells | Apoptosis | MEDICINE, RESEARCH & EXPERIMENTAL | OXIDATIVE STRESS | ALZHEIMERS-DISEASE | IMPAIRMENT | STRATEGIES | PATHOGENESIS | A beta | HONOKIOL | HYPOTHESIS | PHARMACOLOGY & PHARMACY | MICE | INDUCED NEUROTOXICITY | CYTOTOXICITY | Cell Survival - drug effects | Peptide Fragments - metabolism | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Calcium - metabolism | Amyloid beta-Peptides - drug effects | Rats | Thiophenes - pharmacology | Thiones - metabolism | Thiophenes - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Antioxidants - pharmacology | L-Lactate Dehydrogenase - drug effects | PC12 Cells - drug effects | Animals | MAP Kinase Signaling System - drug effects | Neuroprotective Agents - pharmacology | Signal Transduction - drug effects | Peptide Fragments - drug effects | Oxidative Stress - drug effects | Thiones - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Proteins | Development and progression | Alzheimer's disease | Protein kinases | Neuroprotection | Flow cytometry | Bax protein | Calcium | AKT protein | Activation | Kinases | Assaying | Caspase-3 | Pretreatment | Calcium (intracellular) | Neurodegenerative diseases | Neurons | Extracellular signal-regulated kinase | Caspase | Lactate dehydrogenase | Cells | L-Lactate dehydrogenase | 1-Phosphatidylinositol 3-kinase | Pathology | Inhibitors | Protein kinase | Pheochromocytoma cells | β-Amyloid | Lactic acid | Intracellular | Alzheimers disease | Fluo-3 | Viability | Calcium ions
Journal Article
Journal of Inorganic Biochemistry, ISSN 0162-0134, 01/2019, Volume 190, pp. 15 - 23
It is known that copper ion (Cu(II)) binds to amyloid-β peptide (Aβ), induces Aβ oligomer formation and ultimately exacerbates Aβ-aggregation neurotoxicity in... 
Copper ion | Tyrosine nitration | Amyloid-β peptide | Alzheimer's disease | OXIDATIVE STRESS | PROTEIN | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | COMPLEXES | OLIGOMERS | CHEMISTRY, INORGANIC & NUCLEAR | A-BETA(1-42) | Amyloid-beta peptide | A-BETA | HYDROGEN-PEROXIDE | BINDING | AGGREGATION
Journal Article
Journal Article
Sensors & Actuators: B. Chemical, ISSN 0925-4005, 05/2017, Volume 243, pp. 792 - 799
Journal Article
BIOMATERIALS, ISSN 0142-9612, 02/2011, Volume 32, Issue 6, pp. 1635 - 1645
Amyloid beta (A beta) aggregates are considered as possible targets for therapy and/or diagnosis of Alzheimer disease (AD). It has been previously shown that... 
OXIDATIVE STRESS | MATERIALS SCIENCE, BIOMATERIALS | PROTEIN | DEMENTIA | ENGINEERING, BIOMEDICAL | ALZHEIMERS-DISEASE | OLIGOMERS | AQUEOUS-SOLUTION | BINDING-AFFINITY | Alzheimer disease (AD) | Curcumin | Click chemistry | Liposomes | Amyloid beta (A beta) | Structure | AMYLOID-BETA-AGGREGATION | Nanocomposites | Planar structures | Nanomaterials | Affinity | Exposure | Nanostructure | Derivatives
Journal Article
Journal Article